<!DOCTYPE html>
<html lang="en">
  <head>
    <!-- Required meta tags -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

    <!-- Bootstrap CSS -->
    <link href="../css/bootstrap.css" rel="stylesheet" type="text/css">
    <link href="../css/style.css" rel="stylesheet" type="text/css">
</head>
<body>

<nav class="navbar navbar-fixed-top navbar-inverse" style="background-color: #032C4D">
      <div class="container-fluid">
        <!-- Brand and toggle get grouped for better mobile display -->
        <div class="navbar-header">
          <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" 
          	data-target="#bs-example-navbar-collapse-1" aria-expanded="false"> <span class="sr-only">Toggle navigation</span> 
          		<span class="icon-bar"></span> <span class="icon-bar"></span> <span class="icon-bar"></span> </button>
          <a class="navbar-brand" href="#">YJS</a> </div>
        <!-- Collect the nav links, forms, and other content for toggling -->
        <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1">
          <ul class="nav navbar-nav">
			  <li><a href="#"><span class="glyphicon glyphicon-home" aria-hidden="true"></span> My profile <span class="sr-only">(current)</span></a></li>
          
           <li class="dropdown"> <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" 
             	aria-haspopup="true" aria-expanded="false">My Interests<span class="caret"></span></a>
             <ul class="dropdown-menu">    
            	<li class="dropdown-submenu" role="menu"> <a href="#">Web Deveolments</a>
					<ul class="dropdown-menu">
						<li><a href="#">Bootstrap</a></li>
						<li><a href="#">Sass</a></li>
						<li><a href="#">Node JS</a></li>
					</ul>
           	   </li> 
                <li role="separator" class="divider"></li>
                <li class="dropdown-submenu" role="menu"> <a href="#">Programming</a>
					<ul class="dropdown-menu">
						<li><a href="#">Python</a></li>
						<li><a href="#">C++</a></li>
						<li><a href="#">JavaScriipt</a></li>
					</ul>
           	    </li> 
                <li role="separator" class="divider"></li>
				<li><a href="#">One more separated link</a></li>
              </ul>
            </li><!--li-->   
            <li class="dropdown"> <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" 
             	aria-haspopup="true" aria-expanded="false">Drug Discovery<span class="caret"></span></a>
             <ul class="dropdown-menu">    
            	<li class="dropdown-submenu" role="menu"> <a href="#">Protein Kinase</a>
					<ul class="dropdown-menu">
						<li><a href="protin_kinase_A.html">Protein Kinase A</a></li> 
            			<li class="dropdown-submenu" role="menu"> <a href="#">Protein Kinase B</a>
							<ul class="dropdown-menu">
							<li><a href="AKT_PKB_signaling.html">Akt/PKB signaling pathway</a></li>
							<li><a href="protin_kinase_B.html">mTOR inhibitors</a></li>
							<li><a href="protin_kinase_C.html">Protein Kinase C</a></li>
							</ul>
           				</li> 
						<li><a href="protin_kinase_C.html">Protein Kinase C</a></li>
				    </ul>
           		</li> 
                <li role="separator" class="divider"></li>
                <li class="dropdown-submenu" role="menu"> <a href="#">targets</a>
					<ul class="dropdown-menu">
						<li><a href="#">targets A</a></li>
						<li><a href="#">targets B</a></li>
						<li><a href="#">targets C</a></li>
					</ul>
           		 </li> 
                <li role="separator" class="divider"></li>
				<li><a href="#">One more separated link</a></li>
              </ul>
            </li><!--li-->          
            <li class="dropdown"> <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" 
             	aria-haspopup="true" aria-expanded="false">Photography<span class="caret"></span></a>
              <ul class="dropdown-menu">
				  <li><a href="#">Aperture</a></li>
                
                <li role="separator" class="divider"></li>
                <li><a href="#">One more separated link</a></li>
                <li role="separator" class="divider"></li>
                <li class="dropdown-submenu" role="menu"> <a href="#">targets</a>
					<ul class="dropdown-menu">
						<li><a href="#">targets A</a></li>
						<li><a href="#">targets B</a></li>
						<li><a href="#">targets C</a></li>
					</ul>
           		</li> 
                <li role="separator" class="divider"></li>
				<li><a href="#">One more separated link</a></li>
				</ul>
            </li>
		 </ul>
        </div><!-- /.navbar-collapse -->
      </div><!-- /.container-fluid -->
    </nav>

<div class="container-fluid" style="margin-top:50px">
	<div class="row match-my-cols">
		<div class="col-xs-3 sidenav hidden-sm hidden-xs">
			<div class="panel-group" id="accordion" style="margin-top:20px">
				 <div class="panel panel-default">
					  <div class="panel-heading" role="tab">
						<h4 class="panel-title"><a data-toggle="collapse" data-parent="#accordion1" href="#collapseOne1">Collapsible Group 1</a></h4>
					 </div>
						  <div id="collapseOne1" class="panel-collapse collapse in">
							<div class="panel-body"><a href="protin_kinase_A.html">Protein Kinase A</a></div>
							<div class="panel-body"><a href="protin_kinase_B.html">Protein Kinase B</a></div>
							<div class="panel-body"><a href="AKT_PKB_signaling.html">AKT/PKB signaling</a></div>
							<div class="panel-body"><a href="mTOR inhibitors.html">mTOR inhibitors</a></div>
							<div class="panel-body"><a href="protin_kinase_C.html">Protein Kinase C</a></div>
						  </div>
   				</div>
				<div class="panel panel-default">
					<div class="panel-heading">
						<h4 class="panel-title">
							<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo">My Interests</a>
						</h4>
					</div>
					<div id="collapseTwo" class="panel-collapse collapse">
						<div class="panel-body">
							<p>Bootstrap is a powerful front-end framework for faster and easier web development. It is a collection of CSS and HTML conventions. <a href="https://www.tutorialrepublic.com/twitter-bootstrap-tutorial/" target="_blank">Learn more.</a></p>
						</div>
					</div>
				</div>
				<div class="panel panel-default">
					<div class="panel-heading">
						<h4 class="panel-title">
							<a data-toggle="collapse" data-parent="#accordion" href="#collapseThree">Photography</a>
						</h4>
					</div>
					<div id="collapseThree" class="panel-collapse collapse">
						<div class="panel-body">
							<p>CSS stands for Cascading Style Sheet. CSS allows you to specify various style properties for a given HTML element such as colors, backgrounds, fonts etc. <a href="https://www.tutorialrepublic.com/css-tutorial/" target="_blank">Learn more.</a></p>
						</div>
					</div>
				</div>
			</div>
		</div>


		<div class="col-xs-12 col-md-9">
		  <div class="container-fluid">

			<span class="label label-default">Default</span>
			<span class="label label-primary">Primary</span>
			<span class="label label-success">Success</span>
			<span class="label label-info">Info</span>
			<span class="label label-warning">Warning</span>
			<span class="label label-danger">Danger</span>
				<section class="text-justify">
				   <div class="panel panel-default">
				   <div class="panel-body">
					  <h1>Protein  kinase B</h1>
					  <p>Protein  kinase B (PKB), also known as Akt, is a <a href="https://en.wikipedia.org/wiki/Serine/threonine-specific_protein_kinase" title="Serine/threonine-specific protein kinase">serine/threonine-specific protein kinase</a> that plays a key role in multiple  cellular processes such as <a href="https://en.wikipedia.org/wiki/Glucose_metabolism" title="Glucose metabolism">glucose  metabolism</a>, <a href="https://en.wikipedia.org/wiki/Apoptosis" title="Apoptosis">apoptosis</a>, <a href="https://en.wikipedia.org/wiki/Cell_proliferation" title="Cell proliferation">cell  proliferation</a>,  transcription and <a href="https://en.wikipedia.org/wiki/Cell_migration" title="Cell migration">cell  migration</a>.</p>
				   </div><!---panel-body--->
				   </div><!---panel--->
				   <h2>1.0  Family members – Isoforms</h2>
				   <p><a href="https://en.wikipedia.org/wiki/Akt1" title="Akt1">Akt1</a> is involved in cellular survival pathways, by inhibiting <a href="https://en.wikipedia.org/wiki/Apoptosis" title="Apoptosis">apoptotic</a> processes. Akt1 is also able to induce <a href="https://en.wikipedia.org/wiki/Protein_synthesis" title="Protein synthesis">protein synthesis</a> pathways, and is therefore a key signaling  protein in the cellular pathways that lead to skeletal muscle hypertrophy, and  general tissue growth. Mouse model with complete deletion of Akt1 manifests  growth retardation and increased spontaneous apoptosis in tissues such as  testes and thymus.  Since it  can block apoptosis, and thereby promote cell survival, Akt1 has been  implicated as a major factor in many types of cancer. Akt (now also called  Akt1) was originally identified as the <a href="https://en.wikipedia.org/wiki/Oncogene" title="Oncogene">oncogene</a> in the transforming <a href="https://en.wikipedia.org/wiki/Retrovirus" title="Retrovirus">retrovirus</a>, AKT8. <a href="https://en.wikipedia.org/wiki/Akt2" title="Akt2">Akt2</a> is an important signaling molecule in the <a href="https://en.wikipedia.org/wiki/Insulin_signal_transduction_pathway_and_regulation_of_blood_glucose" title="Insulin signal transduction pathway and regulation of blood glucose">insulin signaling pathway</a>. It is required to induce glucose  transport. In a mouse which is null for Akt1 but normal for Akt2, glucose  homeostasis is unperturbed, but the animals are smaller, consistent with a role  for Akt1 in growth. In contrast, mice which do not have Akt2, but have normal  Akt1, have mild growth deficiency and display a <a href="https://en.wikipedia.org/wiki/Diabetes" title="Diabetes">diabetic</a> phenotype (<a href="https://en.wikipedia.org/wiki/Insulin_resistance" title="Insulin resistance">insulin  resistance</a>), again  consistent with the idea that Akt2 is more specific for the <a href="https://en.wikipedia.org/wiki/Insulin_receptor" title="Insulin receptor">insulin receptor</a> signaling pathway. Akt isoforms are  overexpressed in a variety of human tumors, and, at the genomic level, are  amplified in gastric adenocarcinomas (Akt1), ovarian (Akt2), pancreatic (Akt2)  and breast (Akt2) cancer. The role of <a href="https://en.wikipedia.org/wiki/Akt3" title="Akt3">Akt3</a> is less clear, though it appears to be predominantly expressed in the  brain. It has been reported that mice lacking Akt3 have small brains.</p>

				   <h2>2.0  Name</h2>
				   <p>The name Akt does not refer  to its function. The &quot;Ak&quot; in Akt was a temporary classification name  for a mouse bred and maintained by <a href="http://www.nap.edu/read/2201/chapter/9#167">Jacob Furth</a> that developed spontaneous thymic lymphomas. The  &quot;t&quot; stands for '<a href="https://en.wikipedia.org/wiki/Thymoma" title="Thymoma">thymoma</a>'; the letter was added when a  transforming retrovirus was isolated from the Ak strain, which was termed  &quot;Akt-8&quot;. When the oncogene encoded in this virus was discovered, it  was termed v-Akt. Thus, the later identified human analogues were named  accordingly.</p>

				   <h2>3.0  Regulation</h2>
				   <h3>3.1  Binding phospholipids</h3>
				   <p>Akt possesses a <a href="https://en.wikipedia.org/wiki/Protein_domain" title="Protein domain">protein domain</a> known as a PH domain, or <a href="https://en.wikipedia.org/wiki/Pleckstrin_homology_domain" title="Pleckstrin homology domain">Pleckstrin  Homology domain</a>, named  after <a href="https://en.wikipedia.org/wiki/Pleckstrin" title="Pleckstrin">Pleckstrin</a>, the protein in which it was first  discovered. This domain binds to <a href="https://en.wikipedia.org/wiki/Phosphatidylinositol" title="Phosphatidylinositol">phosphoinositides</a> with high affinity. In the case of the PH  domain of Akt, it binds either PIP3 (<a href="https://en.wikipedia.org/wiki/Phosphatidylinositol_(3,4,5)-trisphosphate" title="Phosphatidylinositol (3,4,5)-trisphosphate">phosphatidylinositol (3,4,5)-trisphosphate</a>, PtdIns(3,4,5)<em>P</em>3) or  PIP2 (<a href="https://en.wikipedia.org/wiki/Phosphatidylinositol_(3,4)-bisphosphate" title="Phosphatidylinositol (3,4)-bisphosphate">phosphatidylinositol (3,4)-bisphosphate</a>, PtdIns(3,4)<em>P</em>2). This  is useful for control of cellular signaling because the di-phosphorylated  phosphoinositide <a href="https://en.wikipedia.org/wiki/PtdIns(4,5)P2" title="PtdIns(4,5)P2">PIP2</a> is only phosphorylated by the family of  enzymes, PI 3-kinases (<a href="https://en.wikipedia.org/wiki/Phosphoinositide_3-kinase" title="Phosphoinositide 3-kinase">phosphoinositide  3-kinase</a> or PI3-K), and  only upon receipt of chemical messengers which tell the cell to begin the  growth process. For example, PI 3-kinases may be activated by a <a href="https://en.wikipedia.org/wiki/GPCR" title="GPCR">G protein coupled receptor</a> or <a href="https://en.wikipedia.org/wiki/Tyrosine_kinase" title="Tyrosine kinase">receptor tyrosine kinase</a> such as the <a href="https://en.wikipedia.org/wiki/Insulin_receptor" title="Insulin receptor">insulin receptor</a>. Once activated, PI 3-kinase phosphorylates PIP2  to form PIP3.</p>

				   <h3>3.2  Phosphorylation</h3>
				   <p>Once correctly positioned at  the membrane via binding of <a href="https://en.wikipedia.org/wiki/PIP3" title="PIP3">PIP3</a>, Akt can then be phosphorylated by its  activating kinases, phosphoinositide dependent kinase 1 (<a href="https://en.wikipedia.org/wiki/PDPK1" title="PDPK1">PDPK1</a> at threonine 308) and the mammalian target of rapamycin complex 2 (<a href="https://en.wikipedia.org/wiki/MTORC2" title="MTORC2">mTORC2</a> at serine 473), first by mTORC2. mTORC2 therefore functionally acts as the  long-sought PDK2 molecule, although other molecules, including <a href="https://en.wikipedia.org/wiki/Integrin-linked_kinase" title="Integrin-linked kinase">integrin-linked  kinase</a> (ILK) and  mitogen-activated protein kinase-activated protein kinase-2 (<a href="https://en.wikipedia.org/wiki/MAPKAPK2" title="MAPKAPK2">MAPKAPK2</a>) can also serve as PDK2. Phosphorylation by mTORC2 stimulates the  subsequent phosphorylation of Akt by PDPK1. Activated Akt can then go on  to activate or deactivate its myriad substrates (e.g. <a href="https://en.wikipedia.org/wiki/MTOR" title="MTOR">mTOR</a>) via its kinase activity. Besides being a downstream effector of PI  3-kinases, Akt can also be activated in a PI 3-kinase-independent manner. <a href="https://en.wikipedia.org/wiki/TNK2" title="TNK2">ACK1</a> or <a href="https://en.wikipedia.org/wiki/TNK2" title="TNK2">TNK2</a>, a non-receptor tyrosine kinase, phosphorylates  Akt at its tyrosine 176 residue, leading to its activation in PI  3-kinase-independent manner. Studies have suggested that <a href="https://en.wikipedia.org/wiki/Cyclic_adenosine_monophosphate" title="Cyclic adenosine monophosphate">cAMP</a>-elevating agents  could also activate Akt through <a href="https://en.wikipedia.org/wiki/Protein_kinase_A" title="Protein kinase A">protein kinase A</a> (PKA) in the presence of insulin.</p>

				   <h3>3.3  Ubiquitination</h3>
				   <p>Akt is normally <a href="https://en.wikipedia.org/wiki/Phosphorylated" title="Phosphorylated">phosphorylated</a> at position T450 in the turn motif when Akt is  translated. If Akt is not phosphorylated at this position, Akt does not fold in  the right way. The T450-non-phosphorylated misfolded Akt is <a href="https://en.wikipedia.org/wiki/Ubiquitinated" title="Ubiquitinated">ubiquitinated</a> and degraded by the <a href="https://en.wikipedia.org/wiki/Proteasome" title="Proteasome">proteasome</a>. Akt is also phosphorylated at T308 and S473  during <a href="https://en.wikipedia.org/wiki/IGF-1" title="IGF-1">IGF-1</a> response, and the resulting polyphosphorylated  Akt is ubiquitinated partly by <a href="https://en.wikipedia.org/wiki/E3_ligase" title="E3 ligase">E3 ligase</a> <a href="https://en.wikipedia.org/wiki/NEDD4" title="NEDD4">NEDD4</a>. Most of the ubiquitinated-phosphorylated-Akt is degraded by the  proteasome, while a small amount of phosphorylated-Akt translocates to the nucleus  in a ubiquitination-dependent way to phosphorylate its substrate. A  cancer-derived mutant Akt (E17K) is more readily ubiquitinated and  phosphorylated than the wild type Akt. The ubiquitinated-phosphorylated-Akt  (E17K) translocates more efficiently to the nucleus than the wild type Akt.  This mechanism may contribute to E17K-Akt-induced cancer in humans.</p>

				   <h3>3.4  Lipid phosphatases and PIP3</h3>
				   <p>PI3K-dependent Akt  activation can be regulated through the <a href="https://en.wikipedia.org/wiki/Tumor_suppressor_gene" title="Tumor suppressor gene">tumor  suppressor</a> <a href="https://en.wikipedia.org/wiki/PTEN_(gene)" title="PTEN (gene)">PTEN</a>, which works essentially as the opposite of <a href="https://en.wikipedia.org/wiki/PI3K" title="PI3K">PI3K</a> mentioned above. PTEN acts as a <a href="https://en.wikipedia.org/wiki/Phosphatase" title="Phosphatase">phosphatase</a> to dephosphorylate <a href="https://en.wikipedia.org/wiki/PIP3" title="PIP3">PIP3</a> back to <a href="https://en.wikipedia.org/wiki/PIP2" title="PIP2">PIP2</a>. This removes the membrane-localization factor  from the <a href="https://en.wikipedia.org/wiki/Akt" title="Akt">Akt</a> signaling pathway. Without this localization, the  rate of <a href="https://en.wikipedia.org/wiki/Akt" title="Akt">Akt</a> activation decreases significantly, as do all of  the downstream pathways that depend on <a href="https://en.wikipedia.org/wiki/Akt" title="Akt">Akt</a> for activation.<a href="https://en.wikipedia.org/wiki/PIP3" title="PIP3">PIP3</a> can also be de-phosphorylated at the &quot;5&quot; position by the SHIP  family of inositol phosphatases, <a href="https://en.wikipedia.org/wiki/INPP5D" title="INPP5D">SHIP1</a> and <a href="https://en.wikipedia.org/wiki/INPPL1" title="INPPL1">SHIP2</a>. These poly-phosphate inositol phosphatases  dephosphorylate <a href="https://en.wikipedia.org/wiki/PIP3" title="PIP3">PIP3</a> to form <a href="https://en.wikipedia.org/wiki/PIP2" title="PIP2">PIP2</a>.</p>

				   <h3>3.5  Protein phosphatases</h3>
				   <p>The phosphatases in the <a href="https://en.wikipedia.org/wiki/PHLPP" title="PHLPP">PHLPP</a> family, <a href="https://en.wikipedia.org/wiki/PHLPP" title="PHLPP">PHLPP1</a> and <a href="https://en.wikipedia.org/wiki/PHLPP2" title="PHLPP2">PHLPP2</a> have been shown to directly de-phosphorylate, and therefore inactivate, distinct  Akt isoforms. PHLPP2 dephosphorylates Akt1 and Akt3, whereas PHLPP1 is specific  for Akt 2 and Akt3.</p>

				   <h2>4.0  Function</h2>
				   <p>Akt regulates cellular  survival<a href="https://en.wikipedia.org/wiki/Protein_kinase_B#cite_note-pmid15784165-16">[16]</a> and <a href="https://en.wikipedia.org/wiki/Metabolism" title="Metabolism">metabolism</a> by binding and regulating many downstream  effectors, e.g. <a href="https://en.wikipedia.org/wiki/NF-%CE%BAB" title="NF-κB">Nuclear Factor-κB</a>, Bcl-2 family proteins, master lysosomal  regulator <a href="https://en.wikipedia.org/wiki/TFEB" title="TFEB">TFEB</a> and murine double minute 2 (<a href="https://en.wikipedia.org/wiki/MDM2" title="MDM2">MDM2</a>).</p>

				   <h3>4.1  Cell survival</h3>
				   <div class="container-fluid">
					   <div class="row">
						   <img class="center-block img-responsive" border="0" width="1200" height="887" src="img/Signal_transduction_pathways_svg.png" alt="signal transduction">
					   </div>
					   <div class="row">
						   <p>Akt could promote growth  factor-mediated cell survival both directly and indirectly. <a href="https://en.wikipedia.org/wiki/Bcl-2-associated_death_promoter" title="Bcl-2-associated death promoter">BAD</a> is a  pro-apoptotic protein of the <a href="https://en.wikipedia.org/wiki/Bcl-2" title="Bcl-2">Bcl-2</a> family. Akt could phosphorylate BAD on Ser136, which makes BAD dissociate  from the Bcl-2/Bcl-X complex and lose the pro-apoptotic function. Akt could  also activate <a href="https://en.wikipedia.org/wiki/NF-%CE%BAB" title="NF-κB">NF-κB</a> via regulating <a href="https://en.wikipedia.org/wiki/I%CE%BAB_kinase" title="IκB kinase">IκB kinase</a> (IKK), thus result in transcription of  pro-survival genes.</p>
					   </div>
				   </div>

				   <h3>4.2  Cell cycle</h3>
				   <p>Akt is known to play a role  in the <a href="https://en.wikipedia.org/wiki/Cell_cycle" title="Cell cycle">cell cycle</a>. Under various circumstances, activation  of Akt was shown to overcome cell cycle arrest in G1 and G2 phases.  Moreover, activated Akt may enable proliferation and survival of cells that  have sustained a potentially mutagenic impact and, therefore, may contribute to  acquisition of mutations in other genes.</p>

				   <h3>4.3  Metabolism</h3>
				   <p>Akt2 is required for the  insulin-induced translocation of glucose transporter 4 (<a href="https://en.wikipedia.org/wiki/GLUT4" title="GLUT4">GLUT4</a>) to the <a href="https://en.wikipedia.org/wiki/Plasma_membrane" title="Plasma membrane">plasma  membrane</a>. Glycogen  synthase kinase 3 (<a href="https://en.wikipedia.org/wiki/GSK-3" title="GSK-3">GSK-3</a>) could be inhibited upon phosphorylation  by Akt, which results in increase of glycogen synthesis. GSK3 is also involved  in <a href="https://en.wikipedia.org/wiki/Wnt_signalling_pathway" title="Wnt signalling pathway">Wnt</a> signaling cascade, so Akt might be also  implicated in the Wnt pathway. Still unknown role in <a href="https://en.wikipedia.org/wiki/Hepatitis_C_virus" title="Hepatitis C virus">HCV</a> induced <a href="https://en.wikipedia.org/wiki/Steatosis" title="Steatosis">steatosis</a>.</p>

				   <h3>4.4  Lysosomal biogenesis and autophagy</h3>
				   <p>Akt regulates <a href="https://en.wikipedia.org/wiki/TFEB" title="TFEB">TFEB</a>, a master controller of lysosomal biogenesis, by direct phosphorylation at  serine 467. Phosphorylated TFEB is excluded from the nucleus and less active.  Pharmacological inhibition of Akt promotes nuclear translocation of <a href="https://en.wikipedia.org/wiki/TFEB" title="TFEB">TFEB</a>, lysosomal biogenesis and autophagy.</p>

				   <h3>4.5  Angiogenesis</h3>
				   <p>Akt1 has also been  implicated in <a href="https://en.wikipedia.org/wiki/Angiogenesis" title="Angiogenesis">angiogenesis</a> and tumor development. Although  deficiency of Akt1 in mice inhibited physiological angiogenesis, it enhanced  pathological angiogenesis and tumor growth associated with matrix abnormalities  in skin and blood vessels.</p>

				   <h2>5.0  Clinical relevance</h2>
				   <p>Akt is associated with tumor  cell survival, proliferation, and invasiveness. The activation of Akt is also  one of the most frequent alterations observed in human cancer and tumor cells.  Tumor cells that have constantly active Akt may depend on Akt for survival.  Therefore, understanding Akt and its pathways is important for the creation of  better therapies to treat cancer and tumor cells. A mosaic-activating mutation  (c. 49G→A, p.Glu17Lys) in AKT1 is associated with the Proteus Syndrome, which  causes overgrowth of skin, connective tissue, brain and other tissues.</p>

				   <h3>5.1  AKT inhibitors</h3>
				   <p>Because of the Akt functions  above, Akt inhibitors may treat cancers such as <a href="https://en.wikipedia.org/wiki/Neuroblastoma" title="Neuroblastoma">neuroblastoma</a>. Some Akt inhibitors have undergone clinical  trials. In 2007 <a href="https://en.wikipedia.org/w/index.php?title=VQD-002&action=edit&redlink=1" title="VQD-002 (page does not exist)">VQD-002</a> had a phase I  trial. In 2010 <a href="https://en.wikipedia.org/wiki/Perifosine" title="Perifosine">Perifosine</a> reached phase II. but it failed phase III  in 2012.<a href="https://en.wikipedia.org/wiki/Miltefosine" title="Miltefosine">Miltefosine</a> is approved for <a href="https://en.wikipedia.org/wiki/Leishmaniasis" title="Leishmaniasis">leishmaniasis</a> and under investigation for other indications  including HIV.
				   AKT is now thought to be the  &quot;key&quot; for cell entry by <a href="https://en.wikipedia.org/wiki/HSV-1" title="HSV-1">HSV-1</a> and <a href="https://en.wikipedia.org/wiki/Herpes_simplex_virus_2" title="Herpes simplex virus 2">HSV-2</a> (herpes virus: oral and genital,  respectively). Intracellular <a href="https://en.wikipedia.org/wiki/Calcium_in_biology" title="Calcium in biology">calcium</a> release by the cell allows for entry by  the herpes virus; the virus activates AKT, which in turn causes the release of  calcium. Treating the cells with AKT inhibitors before virus exposure leads to  a significantly lower rate of infection. <a href="https://en.wikipedia.org/wiki/MK-2206" title="MK-2206">MK-2206</a> reported phase 1 results for advanced solid tumors in 2011, and  subsequently has undergone numerous phase II studies for a wide variety of  cancer types.In 2013 <a href="https://en.wikipedia.org/wiki/AZD5363" title="AZD5363">AZD5363</a> reported phase I results regarding solid tumors with a study of AZD5363  with <a href="https://en.wikipedia.org/wiki/Olaparib" title="Olaparib">olaparib</a> reporting in 2016. A new type of Akt inhibitor  has been discovered. <a href="https://en.wikipedia.org/wiki/Ipatasertib" title="Ipatasertib">Ipatasertib</a> is in phase II trials for breast cancer.</p>

				   <h3>5.2  Decreased AKT can cause deleterious effects</h3>
				   <p>AKT activation is associated  with many malignancies; however, a research group from <a href="https://en.wikipedia.org/wiki/Massachusetts_General_Hospital" title="Massachusetts General Hospital">Massachusetts General Hospital</a> and <a href="https://en.wikipedia.org/wiki/Harvard_University" title="Harvard University">Harvard  University</a> unexpectedly  observed a converse role for AKT and one of its downstream effector <a href="https://en.wikipedia.org/wiki/FOXO" title="FOXO">FOXOs</a> in <a href="https://en.wikipedia.org/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">acute  myeloid leukemia</a> (AML).  They claimed that low levels of AKT activity associated with elevated levels of  FOXOs are required to maintain the function and immature state of <a href="https://en.wikipedia.org/wiki/Cancer_stem_cell" title="Cancer stem cell">leukemia-initiating cells</a> (LICs). FOXOs are active, implying  reduced Akt activity, in ∼40% of AML patient samples regardless of  genetic subtype; and either activation of Akt or compound deletion of FoxO1/3/4  reduced leukemic cell growth in a mouse model.</p>

				   <h3>5.3  Hyperactivation of AKT can cause deleterious effects</h3>
				   <p>Two recent studies show that  AKT1 is involved in Juvenile Granulosa Cell tumors (JGCT). In-frame  duplications in the pleckstrin-homology domain (PHD) of the protein were found  in more than 60% of JGCTs occurring in girls under 15 years of age.  Interestingly, the JGCTs without duplications carried point mutations affecting  highly conserved residues. The mutated proteins carrying the duplications  displayed a non-wild-type subcellular distribution, with a marked enrichment at  the plasma membrane. This led to a striking degree of AKT1 activation  demonstrated by a strong phosphorylation level and corroborated by reporter  assays. Analysis by RNA-Seq pinpointed a series of differentially expressed  genes, involved in cytokine and hormone signaling and cell division-related  processes. Further analyses pointed to a possible dedifferentiation process and  suggested that most of the transcriptomic dysregulations might be mediated by a  limited set of transcription factors perturbed by AKT1 activation. These  results incriminate somatic mutations of AKT1 as major probably driver events  in the pathogenesis of JGCTs.</p>
				</section>
		  </div>
		</div>
	</div>
</div><!---container-fluid--->
<footer class="container-fluid">
<p>Footer Text</p>
</footer>






<!-- jQuery (necessary for Bootstrap's JavaScript plugins) --> 
<script src="../js/jquery-1.11.3.min.js"></script>
<script src="../js/tether.js"></script>
<!-- Include all compiled plugins (below), or include individual files as needed --> 
<script src="../js/bootstrap.js"></script>
</body>
</html>



